[ad_1]
MINNEAPOLIS, March 20, 2019 / PRNewswire / – The American Academy of Neurology and the American Brain Foundation attribute a Missouri Potamkin Award Winner 2019 for research on Pick & # 39; s, Alzheimer's disease and related diseases, for his work in research on Alzheimer's disease. Randall J. Bateman, MD, of University of Washington School of Medicine at St. Louis, Mo.and a member of the American Academy of Neurology will receive the award at the 71st annual meeting of the American Academy of Neurology, to be held at Pennsylvania Congress Center in Philadelphia cream, May 4-10, 2019.
Bateman will be recognized at the Potamkin Prize jury's presentation on Monday, May 6, at 15:30. Former winners of the Potamkin Award will also be present and will take stock of their research.
Sometimes referred to as the Nobel Prize for Research on Alzheimer's Disease, the Potamkin Award rewards researchers who have contributed to the understanding of Pick's disease, Alzheimer's disease and related disorders. the $ 100,000 The award is an internationally recognized tribute for the advancement of dementia research.
Bateman, who received the 2004 AAN Clinical Research Training Award, receives the award for his research on Alzheimer's disease. His contributions to the understanding of the disease include the development of a new method to determine the effectiveness with which the beta of amyloid is removed from the brain. Beta amyloid is a sticky protein that can accumulate and turn into amyloid plaques in the brain, leading to dementia. Bateman discovered that the process of brain elimination is impaired in people with Alzheimer's disease. He also directs studies on people with an inherited form of the disease and has shown a relationship between the development of brain lesions and the development of symptoms 15 to 20 years later.
Bateman also created a blood test that could detect Alzheimer's disease in its early stages by measuring beta-amyloid levels. According to Mr. Bateman, the blood test can detect amyloid up to 20 years before the development of Alzheimer's disease. Even though research is underway, a blood test for Alzheimer's disease would be less expensive and easier to administer than current methods of detecting beta-amyloid, a PET scan of the brain or a spinal tap to detect the disease. Amyloid in the cerebrospinal fluid.
"A simple blood test could one day be able to detect Alzheimer's disease for the world's population," said Bateman. "The development of effective treatments and prevention methods will have enormous consequences for the lives of families, medical systems and society in general."
When asked to receive the Potamkin Award, Bateman said, "I am honored and honored to join the elite group of Potamkin Award winners and hope that our work will inspire others. researchers while they strive to have a significant impact on dementia research. "
The Potamkin Award is made possible through philanthropic contributions from the Potamkin family New York, Philadelphia cream and Miami. The objective of this award is to help attract the best medical minds and the most dedicated scientists in the world in the field of dementia research. The Potamkin family has been the largest individual donor to the Academy since 1988, providing more than $ 2 million fund the Potamkin Award.
To learn more about dementia, visit BrainandLife.org, site of the free magazine for patients and caregivers of the American Academy of Neurology, devoted to the intersection of neurological diseases and brain health. To follow Brain and life® on Facebook, Twitter and Instagram.
L & # 39; American Brain Foundation brings together researchers and donors to treat diseases and disorders of the brain. Learn more at www.AmericanBrainFoundation.org.
The American Academy of Neurology is the world's largest badociation of neuroscientists and neuroscience professionals, with more than 36,000 members. AAN is dedicated to promoting patient-centered neurological care of the highest quality. A neurologist is a physician with specialized training in the diagnosis, treatment, and management of brain and nervous system disorders such as Alzheimer's disease, stroke, migraine, multiple sclerosis, concussions, Parkinson's disease and epilepsy.
For more information on the American Academy of Neurology, visit AAN.com or find us on Facebook, Twitter, Instagram, LinkedIn and YouTube.
SOURCE American Academy of Neurology
Related Links
http://www.aan.com
[ad_2]
Source link
